SCHEMBL8894591

SCHEMBL8894591

CN1C(=O)CSSCC(=O)N1C

nearest known ligand 0.39

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 3/20 0.39
GSK3B P49841 3/20 0.39
BRD4 O60885 1/20 0.32
BRD2 P25440 1/20 0.32
MGLL Q99685 1/20 0.32
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12360516 0.81 KMT2A (0.41) GSK3AGSK3BBRD4BRD2MGLL
SCHEMBL181791 0.69
SCHEMBL12360461 0.69 BRD4 (0.43) GSK3AGSK3BBRD4BRD2MGLL
SCHEMBL12360507 0.65 BRD4 (0.52) GSK3AGSK3BBRD4BRD2MGLL
SCHEMBL12360493 0.62 POLB (0.33) GSK3AGSK3BBRD4BRD2MGLL
SCHEMBL762799 0.62
SCHEMBL12748060 0.60
SCHEMBL2487901 0.60
SCHEMBL686422 0.59
SCHEMBL762381 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5686450-A Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents ALCON LABORATORIES, INC. (US) 1997-11-11 US claimed